Alaunos Therapeutics, Inc. (TCRT) research
Alaunos Therapeutics, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.57
- As of
Share the TCRT intelligence card
See TCRT live in the terminal
Track TCRT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live TCRT terminal, freeActive signals for TCRT
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in TCRT
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in TCRT
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in TCRT
- mediumEARNINGS_BEAT
Q2-2023: Beat consensus by 10.9% - EPS $-6 vs $-6.732 estimate
- mediumEARNINGS_MISS
Q4-2023: Missed consensus by 6.8% - EPS $-4.9 vs $-4.59 estimate
FREE, NO ACCOUNT
Every signal on TCRT, as it fires
You are seeing 5 of 10 signals recorded on TCRT since 2026-06-03.
The five above landed across 3 days. The other 5 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TCRT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 98973P309 · 2026Q2 | $27K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TCRT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more TCRT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to TCRTand get the insider, 13F, options, and confluence read in one view.